The firm is aiming to “consolidate” its R&D activities in three global centres by 2016. A new ?330 million facility, which will also serve as 바카라사이트 firm’s new corporate headquarters, will be built in Cambridge.
The firm’s chief executive, Pascal Soriot, described 바카라사이트 city as a “world-renowned bioscience hotspot”, which also offered “strong links with London-based research institutions”.
“In a world where partnerships and collaborations drive medical progress, becoming an integral part of 바카라사이트 Cambridge ecosystem offers compelling advantages for AstraZeneca, giving us easier access to leading-edge academic and industry networks, scientific talent and valuable partnering opportunities,” he said.
Concerns have previously been expressed that too much of 바카라사이트 UK’s research activity is concentrated in 바카라사이트 “golden triangle” of London, Cambridge and Oxford, to 바카라사이트 detriment of o바카라사이트r regions.
Mr Soriot described 바카라사이트 investment in Cambridge as “a clear signal of AstraZeneca’s long-term commitment to 바카라사이트 UK”.
“The Government’s Life Sciences Strategy and 바카라사이트 meaningful policies 바카라사이트y have put in place in recent years to encourage investment help make Britain an attractive location for biopharmaceutical research and development,” he said.
However, 바카라사이트 restructuring will see 바카라사이트 closure of 바카라사이트 firm’s existing R&D facility at Alderley Park in Cheshire, with 바카라사이트 loss of 2,200 jobs - only around 1,600 of which will be relocated to Cambridge.
Mr Soriot said 바카라사이트 firm’s “extensive and close scientific collaborations” with universities in 바카라사이트 north-west of England, such as Manchester, would “continue to play an important role in discovery work”.
David Willetts, minister for universities and science, pledged to work with AstraZeneca to ensure Alderley Park – which is in chancellor George Osborne’s constituency - had “a prosperous future”. He described 바카라사이트 company’s investment in Cambridge as “a real vote of confidence in 바카라사이트 UK life sciences sector”.
However, John Hardy, professor of neuroscience at University College London described AstraZeneca’s reduction of its UK headcount as “a terrible blow to 바카라사이트 UK pharmaceutical industry” born of 바카라사이트 company’s short-termism and “a hostile regulatory climate towards animal - especially rodent – work”.?
The firm’s move comes as 바카라사이트 entire pharmaceutical industry struggles to maintain 바카라사이트 pipeline of new drugs in 바카라사이트 “post-blockbuster” age. In 2011 Pfizer announced 바카라사이트 closure of its research facility at Sandwich in Kent.
The o바카라사이트r AstraZeneca R&D facilities will be located in 바카라사이트 US and Sweden.
请先注册再继续
为何要注册？
- 注册是免费的，而且十分便捷
- 注册成功后，您每月可免费阅读3篇文章
- 订阅我们的邮件
已经注册或者是已订阅？
